2001
DOI: 10.3353/omp.6.95
|View full text |Cite
|
Sign up to set email alerts
|

Neurothekeoma of the Oral Cavity: Report of two cases of a distinctive variant and review of the literature.

Abstract: Oral Med Pathol 6(2001) 95 IntroductionNeurothekeoma (NT) including nerve sheath myxoma (NSM), is a rare neoplasm arising from the endoneurium of the peripheral nerves. In 1969, Harkin and Reed (1) were the first to report on this tumor in the dermis, and they termed it "myxoma of the nerve sheath". The tumor was characterized by a lobular proliferation of myxomatous tissue separated by fibrous septa. Subsequently, Gallager and Helwig (2) reported 53 cases of a benign tumor of the dermis and subcutaneous tissu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2013
2013

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Nerve sheath myxoma (NSM) is an uncommon benign peripheral nerve sheath neoplasm first described in 1969 by Harkin and Reed and Scheithauer et al This neoplasm arises most commonly within the dermis and subcutaneous tissues on the face and upper extremities and is extremely rare in the intraoral region . Intraoral NSM was first reported in 1974 by Mincer and Spears and few cases in the oral mucosa were reported so far in the medical literature …”
Section: Introductionmentioning
confidence: 99%
“…Nerve sheath myxoma (NSM) is an uncommon benign peripheral nerve sheath neoplasm first described in 1969 by Harkin and Reed and Scheithauer et al This neoplasm arises most commonly within the dermis and subcutaneous tissues on the face and upper extremities and is extremely rare in the intraoral region . Intraoral NSM was first reported in 1974 by Mincer and Spears and few cases in the oral mucosa were reported so far in the medical literature …”
Section: Introductionmentioning
confidence: 99%